Tag archive for ‘Approval of AndexXa’
Portola: Approval of AndexXa is a Major Positive (PTLA, Buy, $41.19)
Investment Opinion Based on assumptions made in this report, I estimate that AndexXa could be valued by investors at $114 to $ 200 per Portola share by 2023. This makes Portola a very attractive investment opportunity without taking into account any contribution from Bevyxxa which was recently launched in the US and potential pipeline contributions, […]